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The treatment of glomic tumors has been controversial 
since its first description. It can be done with surgery, 
radiotherapy or just expectation. Aim: The objective of this 
paper was to evaluate the effectiveness and complications of 
radiotherapy. Study design: clinical with transversal cohort. 
Material and Method: It was made a retrospective review in 
the charts of the patients with glomus jugulare tumors treated 
with radiotherapy. Disease control was determined by (1) 
no progression of symptoms or cranial nerve dysfunction or 
(2) no progression of the lesion in radiological follow-up. It 
was also evaluated the follow-up period and the sequelae 
of the treatment. Results: Twelve patients were included, 
8 of then women. The follow-up period was from 3 to 35 
years, with a media of 11,6 years. The main symptoms 
were: hearing loss, pulsate tinnitus, dizziness and vertigo. 
The signs were pulsate retrotympanic mass, facial palsy and 
cofosis. The tumors were staged using Fisch’s classification. 
The radiotherapy was performed with linear accelerator with 
dose ranging from 4500-5500 in 4-6 weeks. In the follow-up 
period were possible to identify sequelaes like dermatitis, 
meatal stenosis, cofosis and facial palsy. Discussion: The 
signs and symptoms were the same found in the medical 
literature. The type and dosages of the radiotherapy were 
also the same of others reports. All patients had improvement 
of the symptoms and only one was not considered as having 
disease controlled. Complications were, in general, minor 
complications, with exception of the cofosis and facial palsy. 
Conclusion: Radiotherapy is a viable alternative to treatment 
of these tumors because their good response and low level of 
complications. It should be considered specially in advanced 
tumors where a surgical procedure could bring a high level 
of morbidity.
Key words: radiotherapy, ear, hearing loss,  
paraganglioma, quemodectoma.
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INTRODUCTION
Glomus tumors also known as paragangliomas or 
chemodectomas are the most common neurological neo-
plasm after acoustic neuroma. These tumors are originated 
from glomus bodies or paraganglia, which are structures 
from the neuroendocrine extra-adrenal system usually 
related to sympathetic ganglia.
The treatment of these tumors has been subject of 
controversy since the first study published in the 40’s by 
Guild1 & Rosenwasser2, and may be divided into curative 
and palliative. The only curative treatment available is sur-
gery, and the palliative treatment may include radiotherapy 
or wait and watch protocol. Generally these tumors are 
addressed on individual basis according to the age of the 
patient, the size, type and staging of the tumor.
The objective of this study was to evaluate radiation 
effectiveness and radiotherapy complications for glomus 
tumor of the temporal bone.
MATERIAL AND METHOD
This study included 12 patients with glomus jugulare 
tumor of the temporal bone treated with radiotherapy be-
tween 1960 and 2001 that have been periodically followed 
up at the Otorhinolaryngology Service of Hospital das 
Clínicas de Porto Alegre. The last appointment occurred 
between January 2004 and February 2005. The patients 
with glomus tympanic tumor and those that have exclu-
sively undergone surgery were excluded from the study.
Patients referred to radiotherapy were those that 
refuse to undergo surgical treatment, those with lesions 
considered non-resectable or those that did not have clini-
cal conditions to undergo general anesthesia. Control crite-
ria of the diseased through radiotherapy were (1) absence 
of progression of symptoms or cranial nerve dysfunction, 
and (2) the lesion did not increase according to physical 
examination or radiological control.
The analysis of the charts of the patients included 
information related to personal data (age and gender), 
clinical history, physical examination and audiometry tests 
on diagnosis, initial staging, proposed and conducted 
treatment, and follow-up of the patients. Radiological 
findings were recovered through expert’s opinion made 
by the radiologist. The staging of the tumor was classified 
according to Fisch3 (Table 1). Radiation therapy concerning 
the type, dose and treatment interval was analyzed based 
on final opinion of the radiotherapist after the end of the 
treatment. The follow up of the patients was conducted 
on a consistent basis: monthly reviews during the first 6 
months, then quarterly reviews up to complete 2 years, 
six months review until 5 years of treatment, and annual 
reviews after it. At every appointment patients answered 
questions about symptoms (hypoacusia, pulsatile tinnitus, 
dizziness/vertigo, otorrhea, otalgia, post-radiotherapy 
symptoms and others) it included a detailed and careful 
description of the otoscopy findings. All patients have 
undergone CT (Computerized Tomography) annually to 
evaluate any likely progression of the tumor.
RESULTS
This study carried out in 12 patients included 8 
women (mean age at diagnosis was 50) aged from31-87 
years. The follow up interval ranged from 3 to 35 years 
(mean of 11.6 years). Major symptoms and findings in 
physical examination at diagnosis are included in Table 2. 
The audiometric findings were anacusia in two thirds of the 
patients, mixed loss in 2 patients and conductive loss in 1 
patient. The audiometry of one patient at diagnosis was not 
recovered, and the oldest one available was that performed 
after radiotherapy showing mixed hearing loss in the ear 
affected by the disease. The patient mentioned there was 
no significant change in hearing after treatment.
Data related to each patient are summarized in 
Table 3.
Radiological findings were extremely variable due 
to multidirectional growth of these tumors. The analyses 
of such exams provide us with the opportunity to evalu-
ate tumor extension and perform an accurate staging of 
such lesions. Tumor staging was performed according to 
Fisch’s classification in Table 4. 
The type radiation therapy used was megavolt 
radiation with linear accelerator and dose ranging from 
4,500 to 5,500 Rads during 4 to 6 weeks. Only one patient 
(CMS) received therapy with telecobalt for 8 weeks and 
Table 1. Classification of glomus jugularis tumors of the 
temporal bone as proposed by Fisch (4).
 Type Description
 A Tumors restricted to middle ear (glomus tympanicum 
tumors)
 B Tumors restricted to tympanomastoid site 
 C Tumors involving the infra-labyrinth portion towards the 
petrous apex 
 D1 Tumor with intracranial invasion (<2 cm)
 D2 Tumor with intracranial invasion (>2 cm)
Table 2. Signs and symptoms on diagnosis.
Symptoms N %
Hypoacusia 12 100
Pulsatile Tinnitus 12 100
Dizziness/vertigo 8 66,6
Otorrhea 5 41,6
Otalgia 1 8,3
Facial Palsy 5 41,6
Pulsatile retrotympanic mass 8 66,6
Polypoid mass of the 
External Auditory canal (CAE)* 4 33,3
*CAE = external auditory canal
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‘Name
Age Symptoms Physical Exami-nation Computerized Tomography Est Rxt Follow-up
Gender
IGA
70
F
Pulsatile Tinnitus , Dizzi-
ness & Left Ear hypoacu-
sia. Slow progression of 
Symptoms Over the last 
Two years
Red Mass in 
Inferior quadrants 
of MT Cofosis on 
the Left Ear.
Expansive lesion of the jugular 
foramen To left with bone mastoid 
destruction Hypotympanum, laby-
rinth and External Auditory Canal. 
Erosion of the inferior portion of the 
Internal Auditory Canal and Skull 
base 
C AL (12/2004) Tinnitus Pulsatile 
and mild Hypoacusia. Red-
dish Non-pulsatile mass CT 
with process Stabilization
NRB
61
F
Pulsatile tinnitus , Progres-
sive Hypoacusia of Right 
Ear Dizziness. Facial palsy 
for 1 year. Otorrhea.
Pulsatile polyp 
in External Audi-
tory Canal. Facial 
Palsy level III 
Cofosis.
Expansive lesion of Right jugular 
foramen   with bone erosion  Of 
External Auditory Canal, Mastoid, 
labyrinth, Facial canal and adjacent 
carotid canal 
C AL (02/2005) Mild pulsatile  
Tinnitus and Hypoacusia. 
Reddish pulsatile mass. CT 
with process Stabilization. 
Otalgia.
LCR
87
F
Pulsatile tinnitus & Hypoa-
cusia on Left Ear.
Pulsatile polyp 
in External Audi-
tory Canal. Facial 
palsy grade III. 
Cofosis.
Expansive lesion of Left Jugular fo-
ramen extending to mastoid, hypo 
and mesotympanum, labyrinth & 
petrous apex with no invasion Of 
Internal Auditory Canal CAI.
C AL (04/2004) Mild non- pulsatile 
Tinnitus Hypoacusia and ver-
tigo. Mass found in otoscopy 
Pulsatile. CT stable.
DMA
43
M
Left Ear Pulsatile tinnitus 
Hypoacusia. Dizziness 
with Vertigo seizures. Fa-
cial palsy.
Pulsatile Mass 
Occluding Ex-
ternal Auditory 
Canal LE 
Expansive lesion Left Jugular fo-
ramen with mastoid bone destruc-
tion, Hypotympanum, labyrinth and 
External Auditory Canal Erosion of 
the inferior portion of the Internal 
Auditory Canal and skull base 
D1 AL (08/2004) Sustained Hypoa-
cusia Improvement of Dizzi-
ness and tinnitus. CT With no 
progression signs External 
Auditory Canal Stenosis 
NMZ
73
F
RE Pulsatile tinnitus & hy-
poacusia Dizziness. Facial 
Palsy (03 years).
Massreddish 
behind TM. Facial 
Palsy (level III) 
Mixed loss RE
Expansive lesion jugular foramen 
to the Right extending to  Mesial 
and Hypotympanum Opacifying the 
mastoid.
B AL (01/2004) Expansive lesion  
jugular foramen to the Right 
extending to mesial and 
Hypotympanum Opacifying 
the mastoid.
CSM
43
F
Pulsatile tinnitus, hypoacu-
sia and RE otalgia. Occa-
sional Dizziness Worsen-
ing over the last 2 years
Pulsatile reddish 
Mass Behind TM 
Conductive Loss 
20dB.
Expansive lesion jugular foramen to 
the Right extending to  mesial and 
hypotympanum Eroding mastoid 
and carotid of adjacent canal 
C TC
o
(01/2005) Pulsatile Tinnitus 
Bloody otorrhea Pulsatile 
Mass Behind TM Desqua-
mation of External Auditory 
Canal Cofosis.
DS
46
M
Pulsatile tinnitus and hy-
poacusia RE Dizziness & 
Unbalance. Occasional 
Otorrhea.
Pulsatile Polyp in 
CAE (RE) Cofosis.
Expansive lesion of Right jugular 
foramen with destruction of Mastoid 
structures of the internal ear Ex-
tended to Infratemporal fossa and 
Right Cerebellar Hemisphere 
D2 AL (11/2004) Mild non pulsatile 
Tinnitus and Stable hypoa-
cusia CT With no signs of 
progression Facial Palsy 
External Auditory Canal Ste-
nosis pruritus.
EC
67
M
Pulsatile tinnitus, hypoa-
cusia and Dizziness. Oc-
casional Otorrhea
Pulsatile reddish 
Mass Behind TM 
RE. Cofosis.
Expansive lesion Involving mastoid 
& cochlea, adjacent to carotid 
Canal.
B AL (03/2004) Non pulsatile Tin-
nitus Stable Hypoacusia 
Reddish Mass Behind TM 
Non-pulsatile.
JMG
67
M
Palatal tinnitus, hypoacu-
sia, otorrhea Bloody. Facial 
palsy
Reddish Pulsatile 
Mass in LE CAE 
Facial palsy (level 
II) Cofosis.
Expansive lesion Left jugular fo-
ramen extending to mesotympa-
num and CAE with Bone erosion of 
the petrous region and IAC Fossa 
Invasion posteriorly Sparing me-
ninges
D1 AL (11/2004) Mild pulsatile Tin-
nitus and Stable Hypoacusia 
Reddish Mass behind MT. 
Dermatitis after radiotherapy 
Table 3. Patients that received radiotherapy to treat glomus tumors.
Continue...
755
BRAZILIAN JOURNAL OF OTORHINOLARYNGOLOGY 71 (6) PART 1 NOVEMBER/DECEMBER 2005
http://www.rborl.org.br  /  e-mail: revista@aborlccf.org.br
dose of 5,200 Rads.
The last appointment follow-up dates were between 
January 2004 and February 2005 when data collection was 
finished. Most of the patients mentioned symptoms only if 
they were asked about any specific complaints during pro-
tocol application. The hearing loss remained stable before 
and after radiation therapy in those patients with mixed 
loss (2 patients); however deafness after radiation therapy 
occurred in one case of a patient with conductive loss. 
In general, tinnitus was described and did not cause any 
discomfort for patients, it remained pulsatile in 6 patients 
even after radiotherapy. Physical examination showed the 
presence of retrotympanic tumor in most of the patients, 
and in 41.6% of them the mass was pulsatile.
Radiological controls did not show any progression 
of the disease in all patients, except for one (CMS). This 
patient had undergone CT scan in Dec/2004 showing 
mild increase in the lesion with density of soft parts that 
occupied the tympanic cavity and part of the External 
Auditory Canal. Since the patient did not have any new 
complaints and does not want to undergo rescue surgery, 
he/she is under clinical follow-up. During the follow-up 
period of patients it was possible to find out that all patients 
presented, at different and variable levels, one or more 
effects resulting from radiotherapy. The most common one 
was dermatitis with severe desquamation and fragility of 
the External Auditory Canal skin that occurred in half of 
the patients. The stenosis of the External Auditory canal 
was reported in 25% of the patients during follow-up. 
Other complications such as otalgia, vertigo, cofosis and 
facial palsy occurred only once. One patient eventually 
presented a basal cell carcinoma in the face and neck 
approximately 30 years after radiotherapy on the same 
irradiated side.
DISCUSSION
Surgery is advocated by many as the ideal 
treatment4,8. It is justified due to technical developments 
of skill base surgery, tumor resectability has enabled good 
functional results, decreased effects and good quality of 
life postoperatively. Recurrence indexes varied from 5.5 
to 54%.4, 17, 18 Surgery morbidity is high and fairly variable, 
leading to primarily cranial nerve dysfunction and liquor 
fistula. In one study of Jackson et al. 4, lesion index of cra-
nial nerves just after the surgery reached 59% of patients. 
It was reported that total removal of the tumor without 
affecting cranial nerves was referred as possible in only 
31% of the cases. Cace et al. 19 had lesion at least of some 
cranial nerve in all patients. Hawthorne et al 20 reported 
47% of cranial nerve dysfunction preoperatively and 95% 
dysfunction postoperatively. Liquor fistula was found in 
12 to 64% of the patients4,19,20. Gardner et al. 8 reported 
50% of dysphagia, 19% of facial palsy postoperatively and 
19% of liquor fistula. Perioperative mortality varied from 
2.7 to 3%4,21. Surgery resulted in cure of the disease in 54 
to 85% of the cases4,9,16, however, long-term effectiveness 
still needs to be determined.
Others view radiotherapy as the initial treatment5,9,11 
due to the morbidity of surgical procedure. The objective 
is to have local/regional control of the disease in the long 
term, without any subjective our objective progression 
of the disease. Typically disease control is defined as in 
the current study: absence of progression of symptoms 
‘Name
Age Symptoms Physical Exami-nation Computerized Tomography Est Rxt Follow-up
Gender
NL
60
F
LE Hypoacusia, bloody 
otorrhea
Reddish Pulsatile 
Mass Bulging 
TM Facial Palsy. 
Cofosis.
Expansive lesion of Left  jugular 
foramen with invasion of middle 
ear and CAE Internal ear preserved 
Involve internal Carotid.
B AL (12/2004) Mild Tinnitus, hy-
poacusia Stable CT with no 
Progression of lesion Nor 
CAE stenosis.
NSO
75
F
LE Pulsatile tinnitus hy-
poacusia Non-rotation 
Dizziness 
Reddish Pulsatile 
Mass Bulging TM 
Cofosis LE
Expansive lesion  next to Left jugu-
lar gulf Extending to-carotid canal, 
mastoid and tympanic cavity With 
destruction of basal cochlear spiral 
C AL (11/2004) Stable Hypoacusia 
And mild pulsatile tinnitus 
Pulsatile Mass In inferior 
quadrants Progression-free 
CT Stable lesion Dermatitis 
LLD
61
F
RE Pulsatile tinnitus and 
Hypoacusia. Facial palsy.
Reddish Pulsatile 
Mass Bulging TM 
Facial palsy level 
V. Cofosis.
Expansive lesion  next to Left jugu-
lar gulf Extending to carotid canal, 
mastoid Tympanic cavity with co-
chlear and petrous portion erosion 
Posterior fossa Invasion.
D1 AL (01/2004) Tinnitus (1/2004) 
Stable Hypoacusia And mild 
Pulsatile tinnitus Pulsatile 
Mass In inferior quadrants 
Stable CT Lesion, dermatitis 
Table 3. Patients that received radiotherapy to treat glomus tumors. (continuation)
Est: staging, Rxt: Radiotherapy, AL: Linear accelerator, TCo: telecobalt, CAE: External Auditory Canal, TM: Tympanic Membrane .
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or cranial nerve dysfunction without any lesion increase 
upon physical examination or radiological control. Tumors 
may present a decrease in size, but rarely disappear as 
observed in pathophysiological analysis of follow-up and 
radiological tests. A study from Spector et al.6 showed that 
chief cells are not radiosensitive, remaining viable after 
radiotherapy. These cells, however, no longer presented 
mitotic activity. The stroma showed itself as more reactive 
to radiotherapy and was replaced by fibrous tissue rich in 
fibroblasts, similarly to vascularization in which one may 
observe changes such as perivascular fibrosis, endothelial 
hyperplasia and subendothelial degeneration.
In the presented series it was possible to find 2:1 
ratio favorable to women, which is somewhat different 
from the literature that sets a ratio of 4 to 7:14, 9.The age 
range of onset of tumors was 43 to 87 years (mean 62.4 
years) a little higher then reported in literature, with higher 
incidence of tumors occurring between 5th and 6th dec-
ades. Mean follow up considered as appropriate was more 
than 11 years to determine a definitive response to the 
treatment, although it is known that glomus tumors have 
slow growth rate and some reports mention a recurrence 
of tumors even after twenty years9.
Symptoms and findings of physical and additional 
examinations were not different from those reported in 
the literature14,15, with a long interval between the onset of 
symptoms and diagnosis14. None of the patients obtained 
improvement in symptoms such as hearing loss, tinnitus 
or cranial nerve dysfunction after radiotherapy, as found 
in other series13,22.
The type of radiotherapy applied was linear ac-
celerators. The dose and term of the radiotherapy were 
also not different from those used in routine medical 
practice7,9,12,13. Some studies used irradiation with cobalt, 
whereas others used linear accelerator. Both radiotherapy 
types are considered as megavoltage radiotherapy, and a 
difference in results was not expected between one and 
the other.
Most of the studies about radiotherapy for glomus 
tumors did not explicitly refer complications, only the 
term “few complications” was mentioned. In the inves-
tigated series it was possible to observe that all patients 
had some degree of complications. Actinic dermatitis after 
radiotherapy may really be considered a minor event, 
and may be controlled with skin medicines and frequent 
cleaning of the External Auditory Canal. On the other 
hand, the presence of stenosis in soft tissue of the External 
Auditory Canal cannot be neglected since it may hinder 
proper postoperative examination, and affect hearing as 
well (although most of the patients had anacusia in the 
affected ear).
Cofosis and facial palsy after radiotherapy are con-
sidered major complications of radiotherapy. The patient 
with hearing loss symptom after treatment (CMS) was ir-
radiated with telecobalt (5,200 Rads) for 26 days; this dose 
is not considered high if compared against data from the 
literature. The same patient was the only one considered 
as therapeutic failure since there was increase in the tumor 
in the follow-up tomography.
In other series, many patients were treated with 
cobalt at similar doses and reported good results without 
any significant complications. Therefore, the treatment 
should not be held responsible for complications or treat-
ment failure. The patient developed facial palsy and had 
a tumor with extensive bone destruction and intracranial 
involvement, and palsy could have resulted from the in-
vasion of the nerve since only tumor abnormalities could 
be found after radiotherapy. In the patient that had basal 
cell carcinoma it was not possible to determine if it was 
a consequence of radiotherapy applications or if it would 
develop anyway since the patient is a rural worker and 
had long history of sunlight exposure.
The control of the disease in our series was con-
sidered satisfactory and successful in 91.6% of the cases. 
Other authors also demonstrated long-term control of 
glomus jugulare tumor with radiotherapy. They report suc-
cess rates ranging from 84 to 98% with the recommended 
dose. Hatfield et al 23 had 100% control in 16 patients with 
doses ranging from 4,000 or above cGY and also reported 
that each 1 out of 2 respected cases that had cure as the 
objective, relapsed. Kim12 demonstrated that radiotherapy 
alone had an 88% rate of disease control, whereas post-
resection subtotal radiotherapy had 85% of disease control. 
Larner presented a study carried out in 49 patients. Twenty 
had undergone surgery, 14 had undergone surgery and 
postoperative radiotherapy, and 15 were treated only with 
radiotherapy, and the other surgeries associated or not 
with post-operative radiotherapy. Disease control with 
radiotherapy was 93%. Radiotherapy has not received the 
recognition it deserves because new techniques that use 
megavoltage are not widely disseminated in clinical prac-
tice yet. In the past, orthovoltage was highly related with 
frequent complications and lack of predictable response 
in disease control. Another key aspect was the fact that 
“chief cells” are radio resistant, and it brings some level 
of concern, but at the same time one should bear in mind 
that the vascular portion of the tumor presents fibrosis 
only after irradiation. The lack of a consistent definition 
Table 4. Patients’ Staging
 Staging N (%)
 A 0
 B 3 (25%)
 C 5 (41,6%)
 D1 3 (25%)
 D2 1 (8,3%)
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about the success in treating glomus jugulare tumors in 
the literature affects the comparisons between different 
treatment regimes.
CONCLUSION
As to radiation treatment for glomus jugulare tu-
mors, since it presents a good response in disease control 
with low morbidity, it is a therapeutic option that should 
be taken into account if the patient is not qualified or does 
not want to undergo surgery. It should also be considered 
in more advanced stage tumors in which resection would 
likely to be incomplete or would result in irreversible 
consequences for the patient. 
The exposure of all treatment vantages and dis-
advantages and likely complications of several treatment 
methods of pathology is in our opinion the correct ap-
proach to allow us to provide better quality medical 
practice. 
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